Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-27

Clinical Trial Update: Effects of Intentional Weight Loss Interventions in Chronic Kidney Disease [Phase 2, Phase 3]

View source ↗

Summary

The Cleveland Clinic-sponsored trial program evaluates intentional weight loss interventions in adults with chronic kidney disease and obesity; Phase 2 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Cleveland Clinic | Conditions: Chronic Kidney Disease, Obesity | Phase 2, Phase 3 | Status: COMPLETED